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ABSTRACT
The use of paired Cas9 nickases instead of Cas9 nu-
clease drastically reduces off-target effects. Because
both nickases must function for a nickase pair to
make a double-strand break, the efficiency of paired
nickases can intuitively be expected to be lower than
that of either corresponding nuclease alone. Here,
we carefully compared the gene-disrupting efficiency
of Cas9 paired nickases with that of nucleases. In-
terestingly, the T7E1 assay and deep sequencing
showed that on-target efficiency of paired D10A Cas9
nickases was frequently comparable, but sometimes
higher than that of either corresponding nucleases
in mammalian cells. As the underlying mechanism,
we found that the HNH domain, which is preserved
in the D10A Cas9 nickase, has higher activity than
the RuvC domain in mammalian cells. In this study,
we showed: (i) the in vivo cleavage efficiency of the
HNH domain of Cas9 in mammalian cells is higher
than that of the RuvC domain, (ii) paired Cas9 nick-
ases are sometimes more efficient than individual
nucleases for gene disruption. We envision that our
findings which were overlooked in previous reports
will serve as a new potential guideline for tool se-
lection for CRISPR-Cas9-mediated gene disruption,
facilitating efficient and precise genome editing.
INTRODUCTION
Programmable nucleases and nickases are versatile tools for
targeted gene editing in cells and organisms (1). For such en-
zymes to be useful, high on-target efficiency and a low fre-
quency of off-target effects are required. RNA-guided Cas9
nucleases, which generate double-strand breaks (DSBs) at
targeted sites in the genome, have significant off-target
effects (2–4). A mutant version of Cas9, Cas9 nickase
(Cas9n), generates single-strand nicks inDNA. Paired nick-
ases, which effectively createDSBs by generating two single-
strand breaks a short distance apart at a targeted site, have
been introduced to reduce such off-target activity (5–8).
Several independent studies have clearly shown that the fre-
quencies of off-target effects generated by paired nickases
are orders of magnitude lower than those of nucleases tar-
geting either of the two nickase sites (5,6,9). However, the
efficiencies of nucleases and paired nickases have not been
extensively compared, although it has been proposed that
the on-target efficiency of paired nickases would be fre-
quently lower or at least comparable to that of either nu-
clease (5,6,10). Given that the efficiency of Cas9 nuclease is
significantly affected by the amount of plasmid DNA en-
coding the single guide RNA (sgRNA) and Cas9 (3) that
is transfected into cells, an exact comparison may require
both the transfection of the same amount of plasmid DNA
and the use of a control plasmid in the nuclease group to al-
low equal expression of sgRNA and Cas9 or Cas9n. Three
previous studies that compared the on-target efficiencies of
nucleases and paired nickases did not monitor the transfec-
tion efficiency or use such a control plasmid (5,6,11).
For a nickase pair to make a DSB, both nickases must
be functional. Thus, the efficiency of paired nickases can
usually be expected to be comparable or slightly lower
than that of either nuclease alone. However, to our sur-
prise, a careful comparison of the efficiencies of 28 D10A
Cas9 nickase pairs with their corresponding 56 Cas9 nu-
cleases showed that the paired nickases frequently exhib-
ited comparable or sometimes significantly higher on-target
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efficiency than the individual nucleases. Infrequently, we
found that the paired nickases showed significantly lower
on-target efficiency than the corresponding nucleases. Inter-
estingly, paired nickases sometimes lead to significant gen-
eration of insertions or deletions (indels) despite insignifi-
cant mutation frequencies associated with either of the cor-
responding nucleases. We also elucidated that the underly-
ing mechanism is the superior activity of the HNH domain,
which is preserved in the D10A Cas9 nickase, compared
to that of the RuvC domain. We envision that our findings
will serve as a potential new guideline for efficient genome
editing tool selection and facilitate the use of Cas9 nickases
and nucleases for efficient and specific genome engineering
strategies.
MATERIALS AND METHODS
Nuclease and nickase constructs
The hSpCas9n nickase (Cas9n; D10A)-expressing pX335
plasmid (#42335) and hSpCas9 nuclease-expressing pX330
plasmid (#42230) (12) were purchased from Addgene
(Cambridge, MA, USA). Using the QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA, USA),
we modified the sgRNA cloning sites of pX335 and pX330
by adding two guanine nucleotides at the 5′ end of the
sgRNA (5′-GGX20 sgRNA) (6) or one guanine nucleotide
at the 5′ end of the sgRNA (5′-GX20/GX19 sgRNA) and
by changing the BbsI restriction enzyme recognition site
(GAAGAC) to that of BsaI (GGTCTC). These nuclease
and nickase constructs with no tagged fluorescent proteins
were used for surrogate reporter assay. To generate U6-
sgRNA-Cas9n-IRES-eGFP and U6-sgRNA-Cas9n-IRES-
mCherry plasmids, IRES-eGFP and IRES-mCherry, re-
spectively, were PCR-amplified using MSCV-IRES-eGFP
and IRES3-mCherry-CL plasmids (kindly provided by
Prof. ChungHeeYong and Prof. ChangHwan Park, respec-
tively, Hanyang University, South Korea) as templates and
then inserted between the Cas9n sequence and the 3′ NLS
of pX335. Similarly, we inserted IRES-eGFP and IRES-
mCherry between the Cas9 sequence and the 3′ NLS of
pX330 to generate U6-sgRNA-Cas9-IRES-eGFP and U6-
sgRNA-Cas9-IRES-mCherry. To generate RuvC-mutant
Cas9 (D10A), HNH-mutant Cas9 (H840A or N863A), site
directed mutagenesis was performed using a QuikChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA).
The full sequences and maps of these vectors are shown in
Supplementary Notes 1–4 and Supplementary Figure S1,
respectively.
The sgRNA target sequences were cloned into the vec-
tors as previously described (13). Briefly, oligonucleotides
containing each target sequence were synthesized (Bioneer,
Seoul, South Korea) and annealed in vitro using a thermo-
cycler. The vector was digested with BsaI restriction enzyme
and ligated with the annealed oligonucleotides. Oligonu-
cleotide sequences are listed in Supplementary Tables S1–6.
Reporters
Flow cytometric reporter plasmids containing a Cas9 target
sequence were constructed as previously described (13,14).
Briefly, oligonucleotides including target sequences (Sup-
plementary Table S7) were synthesized (Bioneer, Daejon,
South Korea) and annealed in vitro using a thermocy-
cler (95◦C for 5 min and then ramped down to 25◦C at
5◦C/min). The annealed oligonucleotides were ligated into
the reporter vectors digested with EcoRI and BamHI.
Cell culture
Human embryonic kidney 293T (HEK293T) cells, human
cervical cancer (HeLa) cells, human chronic myelogenous
leukemia (K562) cells, mouse embryonic fibroblast cell
line (NIH3T3) and mouse neuroblastoma (Neuro-2a) cells
were purchased from American Type Culture Collection
(Manassas, VA). HEK293T, HeLa, NIH3T3 and Neuro-
2a cells were maintained in Dulbecco’s Modified Eagle
Medium (DMEM; Invitrogen, Carlsbad, CA, USA), K562
cells were maintained in Roswell Park Memorial Institute
medium (RPMI-1640; Invitrogen, Carlsbad, CA, USA)
supplemented with 100 units ml−1 penicillin, 100 g ml–1
streptomycin, and 10% fetal bovine serum.
Transfection
Cells were transfected with mixtures of plasmids encoding
Cas9n (or Cas9)-IRES-eGFP and Cas9n (or Cas9)-IRES-
mCherry) at a 1:1 weight ratio using polyethyleneimine
(HEK293T and Neuro-2a cells; linear, MW∼25,000; Poly-
sciences, Warrington, PA) or Neon (HeLa and NIH3T3
cells; Invitrogen, Carlsbad, CA) according to the manufac-
turer’s instructions. The Neon transfection conditions used
for HeLa were 1005 pulse voltage, 35 pulse width and 2
pulse number, and those for NIH3T3 cells were 1400 pulse
voltage, 20 pulse width and 2 pulse number. Cells were an-
alyzed three days after transfection.
Flow cytometry
Cells were transfected with plasmids encoding Cas9n (or
Cas9)-IRES-eGFP and Cas9n (or Cas9)-IRES-mCherry).
Three days after transfection, cells were trypsinized and re-
suspended in 2% FBS in PBS. The transfection efficiency
was monitored by the expression of fluorescent proteins
such as eGFP and mCherry using a flow cytometer (FAC-
SAria II; BD Biosciences). Untransfected cells and cells
transfected with either Cas9n-IRES-eGFP or Cas9n-IRES-
mCherry alone were used as controls.
T7E1 assay
The T7E1 assay was performed as previously described
(15,16). Briefly, genomic DNA was isolated using the Wiz-
ard Genomic DNA purification Kit (Promega, Madison,
WI, USA) according to the manufacturer’s instructions.
The region including the paired nickase or nuclease target
site was nested PCR-amplified using appropriate primers
(Supplementary Table S8). PCR was performed in two dif-
ferent reactions. The first PCR reaction condition was:
Template: 300 ng genomic DNA; denaturation at 95◦C for
30 s, annealing at 60◦C for 30 s, extension at 72◦C (exten-
sion time was 1 min/kb); and 25 PCR cycles. The second
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PCR reaction condition was: Template: First PCR ampli-
con sample: distilled water, diluted to 1:200 ratio; denatu-
ration at 95◦C for 30 s, annealing at 60◦C for 30 s, extension
at 72◦C; and 35 PCR cycles. The amplicons were denatured
by heating and annealed to allow formation of heterodu-
plex DNA, which was treated with 5 units of T7 endonucle-
ase 1 (New England Biolabs) for 20 min at 37◦C followed
by analysis using 2% agarose gel electrophoresis. Mutation
frequencies were calculated as previously described based
on the band intensities using ImageJ software and the fol-
lowing equation (17): mutation frequency (%)= 100× (1−
(1 − fraction cleaved)1/2), where the fraction cleaved is the
total relative density of the cleavage bands divided by the
sum of the relative density of the cleavage bands and uncut
bands.
Sequencing analysis
Sequencing of the genomic region including the target
sequence was performed as previously described (13,14).
Briefly, PCR amplicons that included nuclease or paired
nickase target sites were cloned into the T-Blunt vector
(Promega, Madison, WI). Cloned plasmids were sequenced
using the primers used for PCR amplification.
Targeted deep sequencing
The on-target regions about 300 bp within the ge-
nomic DNA were amplified using Pfu DNA polymerase
(Promega, Madison, WI). Equal amounts of the PCR am-
plicons were subjected to paired-end read sequencing using
Illumina MiSeq at Bio Medical Laboratories. The region
including the paired nickase or nuclease target sites were
nested PCR-amplified using appropriate primers (Supple-
mentary Table S9). Indels mapped around the Cas9 nucle-
ase or nickase cleavage site (3 bp upstreamof the PAM)were
considered to be the result of NHEJ-mediated mutagene-
sis induced by the nuclease or paired nickases. The deep se-
quencing data have been deposited to the NCBI Sequence
Read Archive (http://www.ncbi.nlm.nih.gov/sra).
Surrogate reporter assay
The episomal reporter assay was performed as previously
described (13). HEK293T cells were transfected with Cas9
(Addgene #42230)- or Cas9n (D10A andH840A)-encoding
plasmid (Addgene #51130 and #51129), sgRNA-encoding
plasmid and reporter plasmid at 1:1:1 weight ratio. Three
days after transfection, the cells were analyzed using a flow
cytometer (FACSAria II; BDBiosciences). Cells transfected
with reporters alone were used as an analysis control (13).
Statistical analysis
All data were expressed as means ± S.E.M. and statisti-
cal analysis was conducted using GraphPad Prism 5. The
paired t-test was used to compare the mutation frequencies
of paired nickases and either corresponding nuclease. A P
value < 0.05 was considered statistically significant.
RESULTS
Gene disruption efficiencies of paired Cas9 nickases vs. Cas9
nucleases in human and mouse cells
Tomonitor transfection efficiency, we inserted genes encod-
ing fluorescent proteins (eGFP or mCherry) into the plas-
mid vectors that encode sgRNA (5′GGX20) (6) and Cas9
or Cas9n (D10A) (Supplementary Figures S1 and S2). Fur-
thermore, in both nuclease groups, we used a control plas-
mid expressing a control sgRNA so that an equal amount of
plasmid DNA encoding Cas9 or Cas9n and sgRNA would
be transfected in the three groups, i.e. a nickase pair, one
nuclease and the other nuclease.
HEK293T cells were transfected with plasmids encod-
ing either a nuclease or a nickase pair targeting six loci in
human HEK293T cells. Flow cytometry showed that the
fraction of eGFP- and mCherry-positive cells in these three
cell populations was comparable (Supplementary Figures
S3 and S4), indicating similar transfection or delivery of
plasmids in each group. However, to our surprise, for all
the six analyzed loci, the T7E1 assay showed that the in-
del frequencies in cells treated with paired nickases were
higher than those in at least one of the two cell popula-
tions treated with the corresponding nucleases coupled with
sgRNA complementary to the top or bottom strands (here-
after referred to as top [T] and bottom [B] sgRNAs; Supple-
mentary Figure S2C) and were at least comparable to those
in cells treated with nucleases with higher activities (Figure
1A-F). Out of six analyzed loci, cells transfected with plas-
mids encoding either a nuclease or a nickase pair targeting
two genes (EMX1-S1 and MET) were subjected to capil-
lary sequencing. Sequencing results showed that the muta-
tion frequency in cells treated with paired nickases was 47%
versus 25% and 27% in cells treated with nuclease targeting
of the EMX1-S1 gene, while paired nickases was 44% ver-
sus 20% and 22% in cells treated with nuclease targeting of
the MET gene (Supplementary Figure S5), corroborating
the higher efficiency of paired nickases as compared with
those of nucleases. Notably, at two out of the six analyzed
loci, although the activities of one of the two nucleases were
below the detection limit of the T7E1 assay, the correspond-
ing paired nickases showed significant indel-generating ac-
tivities (Figure 1A and B).
To determine whether paired nickases result in a higher
mutation frequency than either corresponding nuclease in
other species as well, we next compared the mutation fre-
quencies of paired nickases and nucleases targeting five loci
in mouse NIH3T3 cells. Flow cytometry showed that the
fraction of eGFP- and mCherry-positive cells in these three
cell populations was comparable (Supplementary Figure
S6), suggesting that similar plasmid transfection occurred
in each group. Similar to findings observed in human cells,
the T7E1 assay showed that the indel frequencies in cells
treated with paired nickases were higher than those in at
least one of the two cell populations treated with the corre-
sponding nucleases and were at least comparable to those
in cells treated with nucleases with higher activities at all
five loci (Figure 1G-K). Out of the five analyzed loci, the
activities of one of the two nucleases at two loci (Mtor-S3,
Tsc2-S1) and those of both nucleases at one locus (Mtor-
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Figure 1. Gene disruption efficiencies of paired D10ACas9 nickases vs. Cas9 nucleases using sgRNA (5′GGX20) and control sgRNA in human andmouse
cells. HEK293T were analyzed 3 days after transfection with plasmids encoding paired Cas9 nickases or Cas9 nuclease, sgRNAs targeting AAVS1-S1 (T1
and B1; A), AAVS1-S2 (T2 and B1; B),MET (T1 and B1; C), EMX1-S1 (T1 and B1;D), VEGFA-S1 (T1 and B1; E), VEGFA-S2 (T1 and B1; F). NIH3T3
were analyzed 3 days after transfection with plasmids encoding paired Cas9 nickases or Cas9 nuclease, sgRNAs targeting Tsc1-S1 (T1 and B1;G), Tsc2-S1
(T1 and B1;H),Mtor-S1 (T1 and B1; I),Mtor-S2 (T1 and B1; J),Mtor-S3 (T1 and B1;K) and fluorescent proteins (i.e., eGFP or mCherry). A sgRNA that
does not target the respective genes was used as a control and is designated as Con. The frequency of Cas9 nuclease- or paired nickases-driven mutations
as determined by the T7E1 assay are shown using bar graph. Error bars were derived from three independent experiments (n = 3). For brevity, statistical
significance was shown only for comparison between a group-of-interest and the paired nickase group, except for the negative control group; *P < 0.05,
**P < 0.01 by paired t-test. (L) Cas9 nuclease- or paired nickase- driven indels determined by the deep sequencing.
S2) were below the detection limit of the T7E1 assay. How-
ever, the corresponding paired nickases showed significant
indel-generating activities at all five analyzed loci, which is
compatible with the results observed in human cells. We
also performed deep sequencing of a representative locus,
Mtor-S3; the indel frequencies in the cells treated with nu-
cleases were 0.067% and 10.4%, whereas that of cells treated
with the corresponding paired nickases was 27% (Figure
1L, Supplementary Table S10), suggesting that paired nick-
ases are frequently more efficient than the corresponding
nucleases.
From a practical point of view, two important factors
need to be considered to make a valid comparison between
paired nickases vs nucleases. First, the addition of two gua-
nine nucleotides at the 5′ end of sgRNA (5′GGX20) ex-
hibited greater specificity, but in some cases the nuclease
activity was significantly reduced (6). This could lead to a
misleading comparison between nuclease and paired nick-
ases. Second, the total amount of transfectedDNA is some-
times a limiting factor. Although the use of nontargeting
sgRNA is appropriate for comparing the efficiencies of nu-
cleases and paired nickases, one might choose to increase
the amount of transfected plasmid encoding a nuclease (i.e.
Cas9 and sgRNA) for enhanced gene disruption instead of
using paired nickases. Thus, we replaced 5′GGX20 sgRNA
with 5′GX20 or 5′GX19 sgRNA and doubled the amount
of transfected Cas9 nuclease plasmids for further compari-
son analysis.
Next, we compared the indel frequencies of cells trans-
fected with plasmids encoding paired nickases and those
transfected with a doubled amount of nuclease-encoding
plasmid targeting 16 loci in human HEK293T cells with-
out control sgRNA. The T7E1 assay showed that increas-
ing the amount of transfected plasmids encoding Cas9 nu-
clease and sgRNA from 1 g to 2 g led to an increase in
indel frequencies at all 16 analyzed loci (Figure 2) which
is compatible with a previous report (3). Similar compar-
ison analysis was performed on 12 loci in mouse Neuro-
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Figure 2. Gene disruption efficiencies of paired Cas9 nickases vs. double the amount of Cas9 nucleases using sgRNA (5′GX20 or 5′GX19) without control
sgRNA in human cells. (A–P) Cas9 paired nickase- or nuclease-driven mutations in the human genes detected by the T7E1 assay. HEK293T were analyzed
3 days after transfection with plasmids encoding paired Cas9 nickases or Cas9 nuclease, 5′GX20 sgRNAs targeting AAVS1-S1 (T1 and B1; A),MET (T1
and B1; B), EMX1-S1 (T1 and B1; C), EMX1-S2 (T1 and B1; D), USP1 (T1 and B1; E), USP3 (T1 and B1; F), USP16 (T1 and B1; G), USP31 (T1 and
B1;H), USP33 (T1 and B1; I), USP47 (T1 and B1; J), VEGFA-S1 (T1 and B1; K), and VEGFA-S2 (T1 and B1; L). HEK293T were analyzed 3 days after
transfection with plasmids encoding paired Cas9 nickases or Cas9 nuclease, 5′GX19 sgRNAs targeting EMX1-S3 (T1 and B1;M), EMX1-S4 (T1 and B1;
N), EMX1-S5 (T2 and B1; O) and MET-S2 (T1 and B1; P). The frequency of Cas9 nuclease- or paired nickases-driven mutations as determined by the
T7E1 assay are shown using bar graph. Error bars were derived from three independent experiments (n= 3). For brevity, statistical significance was shown
only for comparison between a group-of-interest and the paired nickase group, except for the negative control group; *P< 0.05, **P< 0.01, ***P< 0.001
by paired t-test. ‘+’ and ‘++’ denote 1 and 2 g concentrations of Cas9 nucleases or paired Cas9 nickases using top or bottom sgRNAs, respectively.
2a cells without control sgRNA. The T7E1 assay showed
that increasing the amount of transfected plasmids encod-
ing Cas9 nuclease and sgRNA from 1 to 2 g led to an in-
crease in indel frequencies at all 10 analyzed loci (Figure 3),
except for two loci (Tsc2-S1 and Tsc2-S2; Figure 3B and
C), no changes in indel frequencies were observed. Impor-
tantly, the mutation frequencies in cells treated with paired
nickases were sometimes higher than those in at least one
of two cell populations treated with the doubled amount
of corresponding nucleases andwere frequently comparable
to those in cells treated with the doubled amount of nucle-
ases with higher activities (Figures 2 and 3). Furthermore,
in some cases, the mutation frequencies in the paired nick-
ases group were significantly lower than those in either nu-
clease group, suggesting that paired nickases are not always
superior to nucleases regarding efficiency. Taken together,
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Figure 3. Gene disruption efficiencies of paired Cas9 nickases versus double the amount of Cas9 nucleases using sgRNA (5′GX20 or 5′GX19) without
control sgRNA in mouse cells. (A–L) paired Cas9 nickase- or nuclease-driven mutations in the mouse genes detected by the T7E1 assay. Neuro-2a were
analyzed 3 days after transfection with plasmids encoding paired Cas9 nickases or Cas9 nuclease, 5′GX20 sgRNAs targeting Tsc1-S2 (T1 and B1;A), Tsc2-
S1 (T1 and B1; B), Tsc2-S2 (T1 and B1; C),Mtor-S1 (T1 and B1;D),Mtor-S2 (T1 and B1; E),Mtor-S3 (T1 and B1; F),Usp3 (T1 and B1;G),Usp7-S1 (T1
and B1;H) and Usp7-S2 (T1 and B2; I). Neuro-2a were analyzed 3 days after transfection with plasmids encoding paired Cas9 nickases or Cas9 nuclease,
5′GX19 sgRNAs targeting Tsc2-S3 (T1 and B1; J), Tsc2-S4 (T1 and B1; K) and mUSP7-S3 (T1 and B1; L). The frequency of Cas9 nuclease- or paired
nickases-driven mutations as determined by the T7E1 assay are shown using bar graph. Error bars were derived from three independent experiments (n
= 3). For brevity, statistical significance was shown only for comparison between a group-of-interest and the paired nickase group, except for the negative
control group; *P < 0.05, **P < 0.01, ***P < 0.001 by paired t-test. ‘+’ and ‘++’ denote 1 and 2 g concentrations of Cas9 nucleases or paired Cas9
nickases using top or bottom sgRNAs, respectively.
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Figure 4. Comparison of gene disruption efficiencies of paired Cas9 nick-
ases versus Cas9 nucleases in human andmouse cells. Comparison of indel
frequencies associated with nickase pairs and corresponding nucleases or
double the amount of nucleases as measured using the T7E1 assay in hu-
man and mouse cells. Sixteen pairs of sgRNAs targeting human genes and
twelve pairs of sgRNAs targeting mouse genes were used in HEK293T
cells and Neuro-2a cells, respectively. The average values from three inde-
pendent experiments are shown. Representative bar graphs from each ex-
periment are shown in detail in Figures 2 and 3. Error bars represent s.e.m.
***P < 0.001 by paired t-test.
these results show that both of the methods, i.e. replacing
5′GGX20 sgRNAwith 5′GX20/5′GX19 sgRNAand trans-
fecting plasmids with double the amount of corresponding
nucleases, did not significantly affect the results, showing
overall comparable or higher efficiency of paired nickases
over individual nuclease.
Next, we checked mutation indel frequencies for three
human genes (MET, USP33 and VEGFA-S1) in other hu-
man cell lines such as K562 (Supplementary Figure S7A–
C), and HeLa (Supplementary Figure S7D-F), and two
mouse genes (Tsc2-S2 and Mtor-S2) in a mouse cell line
NIH3T3 (Supplementary Figure S8). The cells were treated
with paired nickases and the corresponding nuclease; paired
nickases exhibited similar higher mutation frequency or
higher than those in at least one of the two cell populations
treated with the corresponding nucleases, suggesting that
the comparable or higher efficiency of paired nickases over
the individual nuclease are not cell specific (Supplementary
Figures S7 and S8).
Comparison of the efficiencies of nucleases and paired nick-
ases
We next summarized the T7E1 assay results obtained in
both human and mouse cells to compare the efficiency of
nucleases and paired nickases in general. The average mu-
tation frequency of cells treated with paired nickases was
28.0 ± 1.7%, significantly higher than the frequency in cells
treated with nucleases at a 1 g concentration using top or
bottom sgRNAs (the average ratio of nickase pair/nuclease
= 5.3 ± 2.9, P < 0.001; the average mutation frequency of
nucleases = 13.8 ± 1.3%; please see Figure 4, Supplemen-
tary Table S11). Similarly, the average mutation frequency
of cells treated with paired nickases was 28.0± 1.7%, signif-
icantly higher than the frequency in cells treated with nucle-
ases at twice the concentration (2 g) using top or bottom
sgRNAs (the average ratio of nickase pair/nuclease= 1.4±
0.1, P < 0.001, and the average mutation frequency of nu-
cleases = 21.5 ± 1.2%; please see Figure 4, Supplementary
Table S12).
When the mutation frequency associated with each nick-
ase pair was individually compared with that of either nu-
clease, in 77% (43/56), 7% (4/56), and 9% (5/56) of com-
parisons, the mutation frequency associated with the nick-
ase pair was significantly higher (P< 0.05), trending higher
(0.05 < P < 0.1) without statistical significance, and com-
parable (P > 0.1), respectively (Supplementary Table S11).
In contrast, only 3.5% (2/56) showed that the mutation fre-
quency associated with each nickases pair was significantly
lower than the cell populations treated with the nucleases
using top or bottom sgRNAs, the remaining 3.5% (2/56)
showed that the mutation frequency associated with each
nickases pair was higher than those in at least one of two
cell populations treated with the corresponding nucleases
(Supplementary Table S11), corroborating that the activity
of nickase pairs is overall superior to that of nucleases with
infrequent exceptions.
However, when the mutation frequency associated with
each nickase pair was individually compared with that of
either nuclease at twice the concentration, in 50% (28/56),
9% (5/56), and 29% (16/56) of comparisons, the muta-
tion frequency associated with the nickase pair was sig-
nificantly higher (P < 0.05), trending higher (0.05 < P <
0.1) without statistical significance, and comparable (P >
0.1), respectively (Supplementary Table S12). In contrast,
only 7% (4/56) showed that the mutation frequency associ-
ated with each nickases pair was significantly lower than the
cell populations treated with the double the amount of nu-
cleases using top or bottom sgRNAs. However, 5% (3/56)
showed that the mutation frequencies in cells treated with
paired nickases were higher than those in at least one of two
cell populations treated with the doubled amount of corre-
sponding nucleases and were at least comparable to those
in cells treated with the doubled amount of nucleases with
higher activities (Supplementary Table S12), suggesting that
the efficiency of paired nickases for gene disruption is some-
times higher or comparable to that of a nuclease at twice the
concentration.
The Cas9 HNH domain has higher cleavage activity than the
RuvC domain
To elucidate themechanismunderlying the higher indel gen-
erating activity of paired D10A nickases as compared with
nucleases, we compared the activities of the two nuclease
domains of Cas9: the HNH domain and the RuvC domain,
which are preserved in D10A and H840A Cas9 nickases
(18), respectively. Although an H840A mutation was re-
ported to convert Cas9 into a nicking enzyme, this mutant
has low levels of activity in mammalian cells compared with
another mutant N863A which has been found to inactivate
the HNH domain (19). Thus, we first compared the indel
generating efficiencies of D10A andH840A orN863A nick-
ases at the same target sequence. Using the same sgRNA
pairs and the same target sequences that were used in the
studies described above, we compared the indel frequen-
cies of HEK293T cells transfected with plasmids encoding
D10A Cas9 or H840A or N863A Cas9. The T7E1 assay
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showed that transfection of plasmids encoding D10A Cas9
and a sgRNA pair led to significant gene disruption at fre-
quencies that ranged from 15% to 31% at all five analyzed
loci, whereas the indel frequency was below the detection
limit (<0.5%) in all cell populations transfected with plas-
mids encoding H840A Cas9 or N863A Cas9 and the same
sgRNA pair (Supplementary Figure S9). Although we did
not observe detectable indels using H840A Cas9 or N863A
Cas9,N863ACas9 can induce significant indels in some tar-
get sequences (20).
One can speculate that the lack of indel generating effi-
ciency by H840A or N863A Cas9 could be due to the 3′
overhang generated by H840A or N863A Cas9 (6,7,20). To
rule out the effects of the 3′ overhang, we attempted to de-
sign sgRNAs so that the cleavages by D10A and H840A
paired nickases would lead to aDSBwith a 5′ overhang.We
found an endogenous locus in the human genome where a
D10A sgRNA pair and a H840A sgRNA pair could be de-
signed in a reverse-identical orientation so that the same se-
quences could be targeted using the two sgRNA pairs (Fig-
ure 5A). The T7E1 assay showed that the average muta-
tion frequencies in cells transfected with plasmids encod-
ing the Cas9 nuclease and T1, B2, T3 and B4 sgRNAs at
twice the concentration were 7.6%, 12%, 2.6% and 10%,
respectively (Figure 5B). The mutation frequency in cells
transfected with plasmids encoding D10ACas9 and T1 and
B2 sgRNAs was 18%, whereas the frequency in cells trans-
fected with plasmids encoding H840A Cas9 and T3 and B4
sgRNAs was below the detection limit, suggesting that the
HNHdomainmay bemore efficient than theRuvCdomain.
When two sgRNAs are identical in a reverse orientation,
we cannot rule out the possibility that the sgRNA activi-
ties are different as observed in Figure 5, a potentially com-
pounding factor when comparing D10A and H840A nick-
ase activity. Thus, we next used an identical sgRNA pair
to compare D10A and H840A nickases. For this purpose,
we prepared a palindromic sgRNA pair (T1 and B2) and
three target DNAs (Figure 6A–C). Target DNA A can be
cleaved by the sgRNA pair and D10A nickase with a 6 bp
offset (OS), leading to a DSB with a 40 bp 5′ overhang
(OH). Target DNA B can be cleaved by the sgRNA pair
and H840A nickase with the same offset as target DNA A
cleaved by D10A nickase, leading to a DSB with a 12 bp 5′
overhang. Target DNAC can be cleaved by the sgRNA pair
and H840A nickase with a 34 bp offset, leading to a DSB
with the same length 5′ overhang as target DNA A cleaved
by D10A.
Non-homologous end joining (NHEJ) surrogate re-
porters, previously used to determine the activity of pro-
grammable nucleases (13), were modified to contain target
DNAs A, B or C to compare the activity of D10A and
H840A nickase pairs. When transfected into mammalian
cells, this reporter constitutively expresses RFP and con-
ditionally expresses GFP in the presence of programmable
nuclease activity that generates indels in the target se-
quence (Supplementary Figure S10). When co-transfected
with plasmids encoding programmable nucleases, the per-
centage ofGFP+ cells among the total RFP+ cells (i.e. trans-
fected cells) reflects the nuclease activity. Here, flow cytom-
etry showed that the frequency of GFP+ cells relative to
RFP+ transfected cells (hereafter, G/R) was 0.01% in the
reporter only-transfected cell population and 77% and 74%
in cell populations transfected with double the amount of
plasmids encoding Cas9 nuclease, and T1 and B2 sgRNAs,
respectively, and reporter plasmids containing target DNA
A (Figure 6D), suggesting that both T1 andB2 sgRNAhave
significant activity in the presence of Cas9 and that this re-
porter assay has minimal background signal. The G/R was
88% in the cells cotransfected with the reporter plasmid
containing target DNA A and plasmids encoding D10A
Cas9 nickase and T1 and B2 sgRNAs, versus 26% and 21%
in the cells cotransfected with reporter plasmids containing
target DNA B and C, respectively, and plasmids encoding
H840A Cas9 nickase and T1 and B2 sgRNAs (Figure 6D),
suggesting that D10A nickase has higher cleavage activity
than H840A nickase. We next isolated the reporter plas-
mid and performed the T7E1 assay to evaluate the indel fre-
quency in the targetDNA.Themutation frequency in target
DNAAwas 33%, versus 9% and 12% in target DNA B and
C, respectively (Figure 6E), corroborating that the cleav-
age activity of D10A nickase is higher than that of H840A
nickase. We conducted three more similar experiments us-
ing different transfection methods and different amounts of
plasmids and observed a similar tendency (Supplementary
Figure S11). The higher cleavage activity of D10A nickase
versusH840Anickase indicates that theCas9HNHdomain
has a higher cleavage activity than the RuvC domain.
DISCUSSION
In this study, we report that paired Cas9 nickases are some-
times more efficient for gene disruption than nucleases.
Paired Cas9 nickases have been introduced to reduce off-
target effects associated with Cas9 nucleases. Given that
both members of a nickase pair must function to induce
a DSB, the on-target efficiency of a nickase pair may usu-
ally be expected to be comparable or slightly lower than
that of a nuclease targeting either of the two nickase sites.
This intuitive assumption that the activity of a Cas9 nick-
ase pair would be at best comparable to that of a Cas9 nu-
clease might be one of the reasons for the limited use of
paired nickases compared to nucleases, which is partly sup-
ported by the number of publications;>3000 articles report
on Cas9 nuclease-mediated genome editing, whereas fewer
than 80 describe Cas9 nickase-mediated editing. Given that
knowledge about the general efficiency of programmable
nucleases can facilitate genome editing (1,21), our study will
be of great value to the users of Cas9 nucleases and nick-
ases. In addition, our findings are compatible with the re-
cent study from the Cotta-Ramusino group which demon-
strated that a high rate of gene conversion and DNA le-
sions were found in RuvC-mutant Cas9 (D10A)-induced
5′ overhangs compared with HNH-mutant Cas9 (N863A)-
induced 3′ overhangs (20). In particular, different ends gen-
erated by the Cas9 variants govern different repair path-
ways. For instance, D10A Cas9-induced 5′ overhangs yield
the highest gene correction by HDR compared to N863A-
induced 3′ overhangs, whereas N863A-induced 3′ over-
hangs are primarily engaged in insertions featuring micro-
homologies (20).
Two studies proposed that the mutation efficiencies of
paired nickases are comparable to those of the correspond-
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Figure 5. Comparison of indel generation efficiencies of paired Cas9 D10A nickases versus paired Cas9 H840A nickases using reverse-identical 5′GX19
sgRNAs without control sgRNA. (A) Sequence of the human EMX1-S2 locus with designed sgRNAs (T1, B2, T3 and B4). Reverse-identical sgRNAs (T1
and T3; B2 and B4) are shown in blue letters. sgRNA target sites (T1, B2, T3 and B4) are indicated by red letters and PAM sequences are marked by bold
underlined letters. The cleavage by D10A Cas9 nickase and the sgRNA pair of T1 and B2 leads to a double-strand break with a 5′ overhang. Similarly, the
cleavage by H840A Cas9 nickase and the sgRNA pair of T3 and B4 also leads to a double strand break with a 5′ overhang. Red arrowheads indicate the
cleavage site. (B) The frequency of double the amount of Cas9 nuclease- or paired nickase-driven mutations as determined by the T7E1 assay are shown
using bar graph. Error bars were derived from three independent experiments (n = 3). ‘+’ and ‘++’ denote 1 and 2 g concentrations of Cas9 nucleases or
paired Cas9 nickases using top or bottom sgRNAs, respectively.
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Figure 6. Comparison of indel generation efficiencies of paired Cas9 D10A nickases vs. paired Cas9 H840A nickases using identical 5′GX20 sgRNAs
without control sgRNA. (A–C) Three surrogate reporters containing sequences that can be targeted with a fixed sgRNA pair (T1 and B2; shown in blue
letters) were constructed. sgRNA target sites (T1 and B2) are indicated by red letters and PAM sequences are marked by bold underlined letters. (A) A
sequence that can be targeted by D10A Cas9n and the sgRNA pair with a +6 bp offset. The cleavage is expected to lead to a 40 bp 5′ overhang. (B) A
sequence that can be targeted by H840A Cas9n and the sgRNA pair with a +6 bp offset. The cleavage is expected to lead to a 12 bp 5′ overhang. (C)
A sequence that can be targeted by H840A Cas9n and the sgRNA pair with a +28 bp offset. The cleavage is expected to lead to a 40 bp 5′ overhang.
(D–E) HEK293T cells were analyzed 3 days after transfection with a plasmid encoding Cas9 nickase (D10A or H840A) or double the amount of Cas9
nuclease, plasmids encoding sgRNAs (T1 and B2), and a reporter plasmid containing the target sequence shown above (A, B or C). (D) Representative
flow cytometry. The percentages of GFP+ cells in the total RFP+ cell population (G/R) are shown (e.g. G/R = 77%). (E) The mutation frequencies in the
target sequence of the transfected reporter plasmids detected by the T7E1 assay.
ing nucleases (5,6). Moreover, the mutation frequencies of
paired nickases are higher than those of the nucleases us-
ing the top sgRNA if the offsets of the sgRNA pairs are in
the optimum range of –4 to 20 bp (5), which is compatible
with our conclusion (Supplementary Tables S11 and S12).
However, when the sgRNA pairs are offset by ←4 or >20
bp, the mutation frequencies associated with paired nick-
ases are significantly lower than those associated with either
nuclease, which could be a confounding factor leading to
the previous interpretation that the two mutation frequen-
cies were comparable.
In this study, we carefully compared the efficiencies be-
tween nucleases and paired nickases in both human and
mouse cell lines with different guide RNA structure, i.e.
sgRNA (5′GGX20), which exhibited greater specificity (6),
and sgRNA (5′GX20 or 5′GX19). Our results showed that
the mutation frequencies in cells treated with paired nick-
ases were comparable or higher than those in at least one
of two cell populations treated with corresponding nucle-
ases (Figures 1–3).We noticed, however, that there were sev-
eral differences between our comparison studies on paired
nickases vs nucleases and those conducted by others. First,
we used a proper control plasmid which was cotransfected
in the nuclease group so that the same amount of sgRNA
and Cas9 or Cas9n would be expressed. Second, only the
transfected cell batches showing the fraction of eGFP- and
mCherry-positive cells from three groups (i.e., a nickase
pair, one nuclease and the other nuclease) were compara-
ble in expression and were subjected for further mutation
frequency analysis. Third, a careful comparison was con-
ducted by subjecting equal amounts of genomic DNA ob-
tained from the tested groups for PCR amplification and
further DNA cleavage analysis. Fourth, we analyzed guide
pairs at least three to four times more than the other groups,
which led us to confidently draw a conclusion on the over-
all comparable or sometimes higher efficiencies of paired
nickases over the corresponding nuclease. Thus, considering
all these technical factors, a deterministic approach to de-
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signing appropriately positioned paired sites will lead to im-
proved editing efficiency and suggests that the use of paired
Cas9n over Cas9 nuclease can be beneficial and can be a
good choice for future experimental strategies.
Paired Cas9 nickases have benefits relative to Cas9 nu-
cleases. Paired nickases are more efficient and specific than
Cas9 nucleases. In addition, the overhangs generated by
paired nickases can be used for targeted gene insertion via
NHEJ (5,10,22). One drawback of paired Cas9 nickases,
however, is the requirement for two sgRNAs instead of one.
Based on a consideration of these advantages and disadvan-
tages, researchers can choose a nickase pair or nuclease that
best fits their experimental conditions and purposes. In ad-
dition, in a minor fraction of cases, the activities of paired
nickases are comparable or slightly lower than that of one
of the nucleases.
Despite barely detectable off-target effects, paired nick-
ases have not been predominantly used in genome edit-
ing studies, partly because it has been thought that their
on-target efficiency would be lower than that of nucleases.
However, we showed here that the efficiency of paired nick-
ases is mostly comparable, but occasionally superior to that
of either corresponding nuclease. In addition, our paired
nickase-encoding vectors allow the monitoring of transfec-
tion and the flow cytometric enrichment of mutant cells. We
envision that our findings will suggest a new guideline for
genome editing tool selection and greatly facilitate the use
of paired Cas9 nickases, which may be useful replacements
for Cas9 nucleases when efficient and specific genome edit-
ing is required.
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